Treatment of cancer micrometastasis using a multicomponent chain-like nanoparticle

Journal of Controlled Release

Volumn 173, Issue 1, 2014, Pages 51-58

  Peiris, Pubudu M ^a,b,c   Toy, Randall ^a,c   Abramowski, Aaron ^c   Vicente, Pete ^a,c   Tucci, Samantha ^a,c   Bauer, Lisa ^c   Mayer, Aaron ^a,c   Tam, Morgan ^a,c   Doolittle, Elizabeth ^a,c   Pansky, Jenna ^c   Tran, Emily ^a,c   Lin, Dishen ^a,c   Schiemann, William P ^c   Ghaghada, Ketan B ^d,e   Griswold, Mark A ^b,c   Karathanasis, Efstathios ^a,b,c  

^a Case Western Reserve University   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d TEXAS CHILDREN S HOSPITAL   (United States)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cancer metastasis; Chain like nanoparticle; Nanochains; Radiofrequency triggered drug release; Targeting

Indexed keywords

CANCER METASTASIS; CHAIN-LIKE; DRUG RELEASE; NANOCHAINS; TARGETING;

CHAINS; DRUG DOSAGE; NANOPARTICLES;

DISEASES;

DOXORUBICIN; IRON OXIDE; LIPOSOME; MACROGOL; NANOPARTICLE; NANOSPHERE; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFICACY; DRUG RELEASE; HYDRODYNAMICS; IN VIVO STUDY; LUNG METASTASIS; MICROMETASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RADIOFREQUENCY; TRIPLE NEGATIVE BREAST CANCER;

CANCER METASTASIS; CHAIN-LIKE NANOPARTICLE; NANOCHAINS; RADIOFREQUENCY-TRIGGERED DRUG RELEASE; TARGETING;

ANIMALS; ANTINEOPLASTIC AGENTS; BREAST; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MICE; MICE, INBRED BALB C; NANOPARTICLES; NEOPLASM MICROMETASTASIS;

EID: 84887636254     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.10.031     Document Type: Article

References (51)

1. American Cancer Society Detailed Guide: Breast Cancer 2012
2. D.D. Von Hoff, M.W. Layard, P. Basa, H.L. Davis Jr., A.L. Von Hoff, M. Rozencweig, and F.M. Muggia Risk factors for doxorubicin-induced congestive heart failure Ann. Intern. Med. 91 1979 710 717 (Pubitemid 10218041)
3. H. Maeda, J. Wu, T. Sawa, Y. Matsumura, and K. Hori Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review J. Control. Release 65 2000 271 284 (Pubitemid 30122932)
4. W.J. Gradishar, S. Tjulandin, N. Davidson, H. Shaw, N. Desai, P. Bhar, M. Hawkins, and J. O'Shaughnessy Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer J. Clin. Oncol. 23 2005 7794 7803 (Pubitemid 46657376)
5. D.D. Lasic Doxorubicin in sterically stabilized liposomes Nature 380 1996 561 562
6. D.D. Lasic, and D. Papahadjopoulos Liposomes revisited Science 267 1995 1275 1276
7. T. Safra Cardiac safety of liposomal anthracyclines Oncologist 8 Suppl. 2 2003 17 24 (Pubitemid 37152053)
8. A. Schroeder, D.A. Heller, M.M. Winslow, J.E. Dahlman, G.W. Pratt, R. Langer, T. Jacks, and D.G. Anderson Treating metastatic cancer with nanotechnology Nat. Rev. Cancer 12 2012 39 50
9. P.P. Adiseshaiah, J.B. Hall, and S.E. McNeil Nanomaterial standards for efficacy and toxicity assessment Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2 2010 99 112
10. L.J. Gay, and B. Felding-Habermann Contribution of platelets to tumour metastasis Nat. Rev. Cancer 11 2011 123 134
11. B. Felding-Habermann, R. Habermann, E. Saldivar, and Z.M. Ruggeri Role of beta3 integrins in melanoma cell adhesion to activated platelets under flow J. Biol. Chem. 271 1996 5892 5900
12. O.J. McCarty, S.A. Mousa, P.F. Bray, and K. Konstantopoulos Immobilized platelets support human colon carcinoma cell tethering, rolling, and firm adhesion under dynamic flow conditions Blood 96 2000 1789 1797 (Pubitemid 30661063)
13. M.A. Arnaout, B. Mahalingam, and J.P. Xiong Integrin structure, allostery, and bidirectional signaling Annu. Rev. Cell Dev. Biol. 21 2005 381 410 (Pubitemid 41740640)
14. B. Felding-Habermann, T.E. O'Toole, J.W. Smith, E. Fransvea, Z.M. Ruggeri, M.H. Ginsberg, P.E. Hughes, N. Pampori, S.J. Shattil, A. Saven, and B.M. Mueller Integrin activation controls metastasis in human breast cancer Proc. Natl. Acad. Sci. U. S. A. 98 2001 1853 1858 (Pubitemid 32165587)
15. M. Lorger, J.S. Krueger, M. O'Neal, K. Staflin, and B. Felding-Habermann Activation of tumor cell integrin alphavbeta3 controls angiogenesis and metastatic growth in the brain Proc. Natl. Acad. Sci. U. S. A. 106 2009 10666 10671
16. J.S. Desgrosellier, and D.A. Cheresh Integrins in cancer: biological implications and therapeutic opportunities Nat. Rev. Cancer 10 2010 9 22
17. P.C. Brooks, R.A. Clark, and D.A. Cheresh Requirement of vascular integrin alpha v beta 3 for angiogenesis Science 264 1994 569 571
18. P.C. Brooks, S. Stromblad, R. Klemke, D. Visscher, F.H. Sarkar, and D.A. Cheresh Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin J. Clin. Invest. 96 1995 1815 1822
19. P.M. Peiris, L. Bauer, R. Toy, E. Tran, J. Pansky, E. Doolittle, E. Schmidt, E. Hayden, A. Mayer, R.A. Keri, M.A. Griswold, and E. Karathanasis Enhanced delivery of chemotherapy to tumors using a multicomponent nanochain with radio-frequency-tunable drug release ACS Nano 6 2012 4157 4168
20. Q. Zhang, M. Yang, J. Shen, L.M. Gerhold, R.M. Hoffman, and H.R. Xing The role of the intravascular microenvironment in spontaneous metastasis development Int. J. Cancer 126 2010 2534 2541
21. P.S. Steeg, K.A. Camphausen, and Q.R. Smith Brain metastases as preventive and therapeutic targets Nat. Rev. Cancer 11 2011 352 363
22. P.M. Peiris, R. Toy, E. Doolittle, J. Pansky, A. Abramowski, M. Tam, P. Vicente, E. Tran, E. Hayden, A. Camann, A. Mayer, B.O. Erokwu, Z. Berman, D. Wilson, H. Baskaran, C.A. Flask, R.A. Keri, and E. Karathanasis Imaging metastasis using an integrin-targeting chain-shaped nanoparticle ACS Nano 6 2012 8783 8795
23. T. Terasaki, T. Iga, Y. Sugiyama, Y. Sawada, and M. Hanano Nuclear binding as a determinant of tissue distribution of adriamycin, daunomycin, adriamycinol, daunorubicinol and actinomycin D J. Pharmacobiodyn 7 1984 269 277 (Pubitemid 14062204)
24. B.J. Marafino Jr., S.N. Giri, and D.M. Siegel Pharmacokinetics, covalent binding and subcellular distribution of [3H]doxorubicin after intravenous administration in the mouse J. Pharmacol. Exp. Ther. 216 1981 55 61 (Pubitemid 11167857)
25. K.M. Laginha, S. Verwoert, G.J. Charrois, and T.M. Allen Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors Clin. Cancer Res. 11 2005 6944 6949 (Pubitemid 41428752)
26. P.M. Peiris, E. Schmidt, M. Calabrese, and E. Karathanasis Assembly of linear nano-chains from iron oxide nanospheres with asymmetric surface chemistry PLoS One 6 2011 e15927
27. E. Bolotin, R. Cohen, L. Bar, N. Emanuel, S. Ninio, D. Lasic, and Y. Barenholz Ammonium sulfate gradients for efficient and stable remote loading of amphipathic weak bases into liposomes and ligandoliposomes J. Liposome Res. 4 1994 455 479 (Pubitemid 24130556)
28. E.K. Sloan, N. Pouliot, K.L. Stanley, J. Chia, J.M. Moseley, D.K. Hards, and R.L. Anderson Tumor-specific expression of alphavbeta3 integrin promotes spontaneous metastasis of breast cancer to bone Breast Cancer Res. 8 2006 R20
29. B.A. Pulaski, and S. Ostrand-Rosenberg Mouse 4T1 breast tumor model Curr. Protoc. Immunol. 20 2001 (Chapter Unit 20 22)
30. K. Tao, M. Fang, J. Alroy, and G.G. Sahagian Imagable 4T1 model for the study of late stage breast cancer BMC Cancer 8 2008 228
31. D.M. Dykxhoorn, Y. Wu, H. Xie, F. Yu, A. Lal, F. Petrocca, D. Martinvalet, E. Song, B. Lim, and J. Lieberman miR-200 enhances mouse breast cancer cell colonization to form distant metastases PLoS One 4 2009 e7181
32. G. Gao, L. Tian, J. Hu, I.S. Park, Y.H. Bae, Prevention of metastasis in a 4T1 murine breast cancer model by doxorubicin carried by folate conjugated pH sensitive polymseric micelles, J Control Release, 152 84-89.[32]
33. M.K. Wendt, J. Molter, C.A. Flask, W.P. Schiemann, In vivo dual substrate bioluminescent imaging, J Vis Exp.[33]
34. J.L. Yori, D.D. Seachrist, E. Johnson, K.L. Lozada, F.W. Abdul-Karim, L.A. Chodosh, W.P. Schiemann, R.A. Keri, Kruppel-like factor 4 inhibits tumorigenic progression and metastasis in a mouse model of breast cancer, Neoplasia, 13 601-610.
35. A. Gabizon, D. Goren, A.T. Horowitz, D. Tzemach, A. Lossos, and T. Siegal Long-circulating liposomes for drug delivery in cancer therapy: a review of biodistribution studies in tumor-bearing animals Adv. Drug Deliv. Rev. 24 1997 337 344 (Pubitemid 27112652)
36. P.G. Rose Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer Oncologist 10 2005 205 214 (Pubitemid 40463158)
37. C.M. Perou, T. Sorlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, C.A. Rees, J.R. Pollack, D.T. Ross, H. Johnsen, L.A. Akslen, O. Fluge, A. Pergamenschikov, C. Williams, S.X. Zhu, P.E. Lonning, A.L. Borresen-Dale, P.O. Brown, and D. Botstein Molecular portraits of human breast tumours Nature 406 2000 747 752
38. F. Bertucci, P. Finetti, and D. Birnbaum Basal breast cancer: a complex and deadly molecular subtype Curr Mol Med 12 2012 96 110
39. L. Perreard, C. Fan, J.F. Quackenbush, M. Mullins, N.P. Gauthier, E. Nelson, M. Mone, H. Hansen, S.S. Buys, K. Rasmussen, A.R. Orrico, D. Dreher, R. Walters, J. Parker, Z. Hu, X. He, J.P. Palazzo, O.I. Olopade, A. Szabo, C.M. Perou, and P.S. Bernard Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay Breast Cancer Res. 8 2006 R23
40. F. Bertucci, P. Finetti, N. Cervera, E. Charafe-Jauffret, M. Buttarelli, J. Jacquemier, M. Chaffanet, D. Maraninchi, P. Viens, and D. Birnbaum How different are luminal A and basal breast cancers? Int. J. Cancer 124 2009 1338 1348
41. P. Friedl, and D. Gilmour Collective cell migration in morphogenesis, regeneration and cancer Nat. Rev. Mol. Cell Biol. 10 2009 445 457
42. F.C. Bidard, J.Y. Pierga, A. Vincent-Salomon, and M.F. Poupon A "class action" against the microenvironment: do cancer cells cooperate in metastasis? Cancer Metastasis Rev. 27 2008 5 10
43. G. Kirfel, A. Rigort, B. Borm, and V. Herzog Cell migration: mechanisms of rear detachment and the formation of migration tracks Eur. J. Cell Biol. 83 2004 717 724 (Pubitemid 40123836)
44. F.M. Kievit, Z.R. Stephen, O. Veiseh, H. Arami, T. Wang, V.P. Lai, J.O. Park, R.G. Ellenbogen, M.L. Disis, and M. Zhang Targeting of primary breast cancers and metastases in a transgenic mouse model using rationally designed multifunctional SPIONs ACS Nano 6 2012 2591 2601
45. E. Gavze, and M. Shapiro Particles in a shear flow near a solid wall: effect of nonsphericity on forces and velocities Int. J. Multiphase Flow 23 1997 155 182
46. P. Decuzzi, S. Lee, B. Bhushan, and M. Ferrari A theoretical model for the margination of particles within blood vessels Ann. Biomed. Eng. 33 2005 179 190 (Pubitemid 40509493)
47. E. Gavze, and M. Shapiro Motion of inertial spheroidal particles in a shear flow near a solid wall with special application to aerosol transport in microgravity J. Fluid Mech. 371 1998 (59 ± 79)
48. S.Y. Lee, M. Ferrari, and P. Decuzzi Shaping nano-/micro-particles for enhanced vascular interaction in laminar flows Nanotechnology 20 495101 2009 (11 pp.)
49. F. Gentile, C. Chiappini, D. Fine, R.C. Bhavane, M.S. Peluccio, M.M. Cheng, X. Liu, M. Ferrari, and P. Decuzzi The effect of shape on the margination dynamics of non-neutrally buoyant particles in two-dimensional shear flows J. Biomech. 41 2008 2312 2318
50. P. Decuzzi, and M. Ferrari The adhesive strength of non-spherical particles mediated by specific interactions Biomaterials 27 2006 5307 5314 (Pubitemid 44080296)
51. C.S. Brazel Magnetothermally-responsive nanomaterials: combining magnetic nanostructures and thermally-sensitive polymers for triggered drug release Pharm. Res. 26 2009 644 656